Skip to Content

Evista

In the US, Evista (raloxifene systemic) is a member of the following drug classes: hormones/antineoplastics, selective estrogen receptor modulators and is used to treat Breast Cancer - Prevention, Osteoporosis and Prevention of Osteoporosis.

US matches:

UK matches:

Ingredient matches for Evista

Raloxifene

Raloxifene is reported as an ingredient of Evista in the following countries:

  • Cyprus
  • Denmark
  • Ecuador
  • Egypt
  • Ireland
  • Lebanon
  • Peru
  • Tunisia

Raloxifene hydrochloride (a derivative of Raloxifene) is reported as an ingredient of Evista in the following countries:

  • Argentina
  • Australia
  • Austria
  • Belgium
  • Brazil
  • Canada
  • Chile
  • China
  • Croatia (Hrvatska)
  • Czech Republic
  • France
  • Germany
  • Greece
  • Hong Kong
  • Hungary
  • Indonesia
  • Ireland
  • Israel
  • Italy
  • Japan
  • Lithuania
  • Malaysia
  • Mexico
  • New Zealand
  • Norway
  • Oman
  • Philippines
  • Poland
  • Portugal
  • Romania
  • Singapore
  • South Africa
  • South Korea
  • Spain
  • Switzerland
  • United Kingdom
  • United States
  • Venezuela

International Drug Name Search

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide